Bolt Biotherapeutics BOLT
NASDAQ BOLT
$4.19 +0.01 (+0.17%)
As of: Oct 21, 2026 · 3:56 PM EDT

Bolt Biotherapeutics (BOLT) Preferred Stock Liabilities (2020)

Updated

Bolt Biotherapeutics (BOLT) posted Preferred Stock Liabilities of $105.3 million for Q4 2020, unchanged from the prior quarter.

Analysis

Bolt Biotherapeutics (BOLT) Preferred Stock Liabilities (2020) Analysis & Trends

Since Q1 2020, Bolt Biotherapeutics has reported Preferred Stock Liabilities for 4 quarters.

  • According to Business Quant data, Preferred Stock Liabilities for the three prior quarters was $105.3 million (Q3 2020), $41.3 million (Q2 2020) and $77.51 million (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Bolt Biotherapeutics 8.06 Mn -10.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 105.30 Mn
Sep 30, 2020 105.30 Mn
Jun 30, 2020 41.30 Mn
Mar 31, 2020 77.51 Mn
API Access

Bolt Biotherapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=BOLT&period=max&api_key=YOUR_API_KEY